Hospital-level Intervention Did Not Improve Outcomes or Quality in HFrEF
Key Points: CONNECT-HF, one of the largest heart failure (HF) implementation science…
Pirfenidone Shown to Decrease Fibrosis in Patients with HFpEF
Key Points: Myocardial fibrosis has previously been associated with death and repeat…
Benefits of Sotagliflozin Across Full Spectrum of EF
KEY POINTS: Trials for those with heart failure with preserved ejection fraction…
Transfusion in AMI: More or Less?
A restrictive transfusion strategy may no longer be inferior to a liberal…
Sacubitril/Valsartan Not More Effective Than Valsartan alone in Advanced HF: LIFE trial
Key Points: This is the first study to assess the effects of…
0/1hr or 0/3hr hsTroponin T in Suspected ACS?
Key Points: Among patients with suspected acute coronary syndromes (ACS) and ischemia…
Low Dose Atorvastatin Did Not Reduce Composite Endpoint in Patients with COVID-19
INSPIRATION-S led by Behnood Bikdeli, MD, MS, and presented at the American…
ACTION-Coalition Trial: Therapeutic Dose of Anticoagulation Is Associated With Increased Risk of Bleeding and No Improvement in Clinical Outcomes Among Hospitalized COVID-19 Patients With Elevated D-Dimer Levels
ACTION presented at the American College of Cardiology 2021 meeting by Renato…
No benefit to FFR-guided PCI over angiographic-guided PCI of Nonculprit Lesions after STEMI: Results from FLOWER-MI Show
Key Points: While FFR-guided PCI is superior in chronic coronary syndrome, its…
Additional background and insight
Presented by Dr. Schuyler Jones, assistant professor of medicine, Duke University, and…
REHAB-HF: A Novel Physical Rehabilitation Intervention For Older Patients With ADHF
Key Points: Elderly frail patients with acute decompensated heart failure hospitalizations benefit…
PRADA: Cardioprotective Agents May Not Be Required During Breast Cancer Tx
Adjuvant breast cancer therapy, while beneficial in prolonging survival, has been shown…
TWILIGHT: Analysis Shows Sex Disparities in PCI Outcomes Still Exist
Women fared worse than men in terms of increased bleeding risk, but…
EXPLORER-HCM Trial: Mavacamten Associated With Significant Improvement in Patients’ Health Status in Patients With Symptomatic LV Outflow Tract Obstruction
EXPLORER-HCM presented at the American College of Cardiology 2021 meeting by John…